Finanzwire Finanzwire
Basculer en Français
10000 Companies
202918 Keywords
133504 Articles
107744 Press releases
Headlines Articles Press releases Ascend Advanced Therapies (Ascend) Remove
  1. Home
  2. Companies
  3. Ascend Advanced Therapies (Ascend)
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 11/10/2025 at 18:10, 3 months 29 days ago

    Ascend's Innovation Enhances AAV Production Efficiency

    Gene Therapy Biotechnology Innovation Ascend Advanced Therapies AAV Production Manufacturing Enhancers
  • PRESS RELEASE

    published on 11/10/2025 at 18:05, 3 months 29 days ago

    Ascend Unveils Proprietary Enhancers That Significantly Improve AAV Yields Without Compromising Quality

    Ascend Advanced Therapies unveils proprietary enhancers demonstrating significant improvements in AAV yields and quality attributes for gene therapy programs
    Ascend Advanced Therapies Proprietary Enhancers AAV Yields Gene Therapy Programs Quality Attributes
    Logo of Ascend Advanced Therapies (Ascend)
  • BRIEF

    published on 10/08/2025 at 15:10, 5 months 1 day ago

    Ascend Advanced Therapies Successfully Defends EpyQ® Patent at EPO

    Intellectual Property Gene Therapy European Patent Office Ascend Advanced Therapies EpyQ® AAV Plasmid
  • PRESS RELEASE

    published on 10/08/2025 at 15:05, 5 months 1 day ago

    European Patent on Ascend Advanced Therapies' EpyQ® AAV Plasmid Technology Successfully Defended at the EPO

    Ascend Advanced Therapies successfully defends European patent EP3722434 for EpyQ® AAV plasmid technology at the EPO, reinforcing its position in gene therapy
    Gene Therapy European Patent Ascend Advanced Therapies EpyQ® AAV Plasmid Technology
    Logo of Ascend Advanced Therapies (Ascend)
Accesswire
  • Published on 03/09/2026 at 17:15, 2 hours 4 minutes ago

    Alta Copper Corp. and Nascent Exploration Pty Ltd Announce Completion of Plan of Arrangement

  • Published on 03/09/2026 at 14:00, 5 hours 19 minutes ago

    urban-gro, Inc. Regains Full Nasdaq Compliance Following Balance Sheet and Governance Improvements

  • Published on 03/09/2026 at 14:00, 5 hours 19 minutes ago

    Jaguar Health Strengthens Company's Balance Sheet by Restructuring and Reducing Royalty and Debt Obligations and Extinguishing Warrants

  • Published on 03/09/2026 at 13:00, 6 hours 19 minutes ago

    Avant Brands Continues to Strengthen Balance Sheet with $1.77 Million Debt Retirement at $0.935 Per Unit

  • Published on 03/09/2026 at 13:00, 6 hours 19 minutes ago

    Unusual Machines Fourth Quarter and Full Year 2025 Shareholder Letter

View all ACCESSWIRE
EQS Group
  • Published on 03/09/2026 at 19:05, 13 minutes ago

    Ridgewood Infrastructure Acquires Sierra Railroad Company

  • Published on 03/09/2026 at 18:41, 37 minutes ago

    POS-Transaction in Own Shares

  • Published on 03/09/2026 at 16:30, 2 hours 48 minutes ago

    Huawei Debuts "Driving Mobility and Logistics into the Intelligent World" Vision for Transportation, Powered by Five New Solutions

  • Published on 03/09/2026 at 15:57, 3 hours 21 minutes ago

    Commerzbank completes share buyback of €524m

  • Published on 03/09/2026 at 15:53, 3 hours 25 minutes ago

    Commerzbank completes share buyback of €524m

View all EQS
Les Echos
  • Published on 03/09/2026 at 18:43, 36 minutes ago

    Reporting on share buyback transactions carried out between March 2 and March 6, 2026

  • Published on 03/09/2026 at 18:00, 1 hour 19 minutes ago

    CEGEDIM: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS

  • Published on 03/09/2026 at 17:45, 1 hour 34 minutes ago

    Disclosure of Share Capital and Voting Rights Outstanding as of February 28, 2026

  • Published on 03/09/2026 at 17:35, 1 hour 44 minutes ago

    Disclosure of transactions in own shares from March 2 to March 6, 2026

  • Published on 03/09/2026 at 08:45, 10 hours 34 minutes ago

    Share buyback

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy